Caricamento...
IT-06 PERSONALIZED IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA
BACKGROUND: Immunotherapy harnesses the immune system to specifically attack malignant cells thereby offering a targeted treatment option without systemic toxicity for patients with GBM. However, immunotherapy remains limited by the relative dearth of antigen specific tumor targets. Since GBMs have...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218256/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou258.5 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|